$0.37
-0.2322[-38.56%]
At close: Mar 27
$0.37
0[0.00%]
PreMarket: 4:00PM EDT
Agile Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Agile Therapeutics using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
05/09/2024 | PM | AGRX | Q1 | -$7.76 | -$0.51 | — | — | $3.81M | $3.75M | — | — | Get Alert |
03/28/2024 | AM | AGRX | Q4 | -$9.00 | -$0.92 | -$1.46 | -58.70% | $4.00M | $4.07M | $3.62M | -11.18% | Get Alert |
11/09/2023 | AM | AGRX | Q3 | -$11.50 | -$1.84 | -$1.47 | 20.11% | $3.00M | $5.27M | $6.66M | 26.41% | Get Alert |
08/09/2023 | AM | AGRX | Q2 | -$135.50 | -$3.48 | -$3.10 | 10.92% | $2.13M | $4.68M | $5.50M | 17.59% | Get Alert |
05/11/2023 | PM | AGRX | Q1 | -$189.00 | -$7.50 | -$7.76 | -3.47% | $1.76M | $3.40M | $3.81M | 12.15% | Get Alert |
03/22/2023 | PM | AGRX | Q4 | -$400.00 | -$11.50 | -$9.00 | 21.74% | $1.51M | $3.08M | $4.00M | 29.74% | Get Alert |
11/07/2022 | PM | AGRX | Q3 | -$360.00 | -$14.50 | -$11.50 | 20.69% | $1.29M | $2.33M | $3.00M | 28.84% | Get Alert |
08/11/2022 | PM | AGRX | Q2 | -$400.00 | -$14.50 | -$135.50 | -834.48% | $1.19M | $1.76M | $2.13M | 20.80% | Get Alert |
05/12/2022 | PM | AGRX | Q1 | -$400.00 | -$240.00 | -$189.00 | 21.25% | $116.00K | $1.22M | $1.76M | 44.34% | Get Alert |
03/30/2022 | PM | AGRX | Q4 | -$400.00 | -$300.00 | -$400.00 | -33.33% | $749.00K | $1.51M | $1.51M | 0.26% | Get Alert |
11/02/2021 | PM | AGRX | Q3 | -$360.00 | -$380.00 | -$360.00 | 5.26% | $0.00 | $1.46M | $1.29M | -11.85% | Get Alert |
07/26/2021 | PM | AGRX | Q2 | -$240.00 | -$420.00 | -$400.00 | 4.76% | $0.00 | $1.95M | $1.19M | -39.23% | Get Alert |
05/04/2021 | PM | AGRX | Q1 | -$200.00 | -$420.00 | -$400.00 | 4.76% | $0.00 | $600.00K | $116.00K | -80.67% | Get Alert |
03/01/2021 | PM | AGRX | Q4 | -$200.00 | -$440.00 | -$400.00 | 9.09% | $0.00 | $1.01M | $749.00K | -25.84% | Get Alert |
11/12/2020 | PM | AGRX | Q3 | -$160.00 | -$360.00 | -$360.00 | 0.00% | $0.00 | — | $0.00 | — | Get Alert |
08/11/2020 | PM | AGRX | Q2 | -$160.00 | -$280.00 | -$240.00 | 14.29% | $0.00 | — | $0.00 | — | Get Alert |
05/05/2020 | PM | AGRX | Q1 | -$260.00 | -$180.00 | -$200.00 | -11.11% | $0.00 | — | $0.00 | — | Get Alert |
02/20/2020 | PM | AGRX | Q4 | -$220.00 | — | -$200.00 | — | $0.00 | — | $0.00 | — | Get Alert |
10/28/2019 | AM | AGRX | Q3 | -$220.00 | — | -$160.00 | — | $0.00 | — | $0.00 | — | Get Alert |
Agile Therapeutics (AGRX) is scheduled to report earnings on May 9, 2024. The last reported earnings were for reported on March 28, 2024 for Q4.
The Actual EPS was $-1.46, which missed the estimate of $-0.92.
The Actual Revenue was $3.6M, which missed the estimate of $4.1M.
Browse earnings estimates, EPS, and revenue on all stocks.